{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:08:31Z","timestamp":1770480511960,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Lung cancers consist of four major types that and for clinical-pathological reasons are often divided into two broad categories: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). All major histological types of lung cancer are associated with smoking, although the association is stronger for SCLC and squamous cell carcinoma than adenocarcinoma. To date, epidemiological studies have identified several environmental, genetic, hormonal and viral factors associated with lung cancer risk. It has been estimated that 15-25% of human cancers may have a viral etiology. The human papillomavirus (HPV) is a proven cause of most human cervical cancers, and might have a role in other malignancies including vulva, skin, oesophagus, head and neck cancer. HPV has also been speculated to have a role in the pathogenesis of lung cancer. To validate the hypothesis of HPV involvement in small cell lung cancer pathogenesis we performed a gene expression profile of transgenic mouse model of SCLC induced by HPV-16 E6\/E7 oncoproteins.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Gene expression profile of SCLC has been performed using Agilent whole mouse genome (4 \u00d7 44k) representing ~ 41000 genes and mouse transcripts. Samples were obtained from two HPV16-E6\/E7 transgenic mouse models and from littermate's normal lung. Data analyses were performed using GeneSpring 10 and the functional classification of deregulated genes was performed using Ingenuity Pathway Analysis (Ingenuity<jats:sup>\u00ae<\/jats:sup>Systems,<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.ingenuity.com\" ext-link-type=\"uri\">http:\/\/www.ingenuity.com<\/jats:ext-link>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Analysis of deregulated genes induced by the expression of E6\/E7 oncoproteins supports the hypothesis of a linkage between HPV infection and SCLC development. As a matter of fact, comparison of deregulated genes in our system and those in human SCLC showed that many of them are located in the Aryl Hydrocarbon Receptor Signal transduction pathway.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this study, the global gene expression of transgenic mouse model of SCLC induced by HPV-16 E6\/E7 oncoproteins led us to identification of several genes involved in SCLC tumor development. Furthermore, our study reveled that the Aryl Hydrocarbon Receptor Signaling is the primarily affected pathway by the E6\/E7 oncoproteins expression and that this pathway is also deregulated in human SCLC. Our results provide the basis for the development of new therapeutic approaches against human SCLC.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1479-5876-9-2","type":"journal-article","created":{"date-parts":[[2011,1,5]],"date-time":"2011-01-05T20:03:32Z","timestamp":1294257812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6\/E7 oncoproteins"],"prefix":"10.1186","volume":"9","author":[{"given":"Tonia","family":"Buonomo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Carraresi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,4]]},"reference":[{"key":"660_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ncponc0984","volume":"5","author":"A Psyrri","year":"2008","unstructured":"Psyrri A, DiMaio D: Human papillomavirus in cervical and head-and neck cancer. Nat Clin Pract Oncol. 2008, 5: 24-31. 10.1038\/ncponc0984.","journal-title":"Nat Clin Pract Oncol"},{"key":"660_CR2","doi-asserted-by":"crossref","unstructured":"Crum CP, McLachlin CM, Tate JE, Mutter GL: Pathobiology of vulvar squamous neoplasia. Curr Opin Obstet Gynecol. 1997, 63-69. 9","DOI":"10.1097\/00001703-199702000-00014"},{"key":"660_CR3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S1470-2045(07)70137-7","volume":"8","author":"O Kayes","year":"2007","unstructured":"Kayes O, Ahmed HU, Arya M, Minhas S: Molecular and genetic pathways in penile cancer. Lancet Oncol. 2007, 8: 420-429. 10.1016\/S1470-2045(07)70137-7.","journal-title":"Lancet Oncol"},{"key":"660_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/jcp.55.10.721","volume":"55","author":"KJ Syrj\u00e4nen","year":"2002","unstructured":"Syrj\u00e4nen KJ: HPV infections and oesophageal cancer. J Clin Pathol. 2002, 55: 721-728. 10.1136\/jcp.55.10.721.","journal-title":"J Clin Pathol"},{"key":"660_CR5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/172460080502000102","volume":"20","author":"ID Lyronis","year":"2005","unstructured":"Lyronis ID, Baritaki S, Bizakis I, Tsardi M, Spandidos DA: Evaluation of the prevalence of human papillomavirus and Epstein-Barr virus in esophageal squamous cell carcinomas. Int J Biol Markers. 2005, 20: 5-10.","journal-title":"Int J Biol Markers"},{"key":"660_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00430-002-0161-y","volume":"192","author":"C Ostwald","year":"2003","unstructured":"Ostwald C, Rutsatz K, Schweder J, Schmidt W, Gundlach K, Barten M: Human papillomavirus 6\/11 16 and 18 in oral carcinomas and benign oral lesions. Med Microbiol Immunol. 2003, 192: 145-148. 10.1007\/s00430-002-0161-y.","journal-title":"Med Microbiol Immunol"},{"key":"660_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000194095","volume":"38","author":"KJ Syrjanen","year":"1979","unstructured":"Syrjanen KJ: Condylomatous changes in neoplastic bronchial epithelium. Report of a case. Respiration. 1979, 38: 299-304. 10.1159\/000194095.","journal-title":"Respiration"},{"key":"660_CR8","first-page":"2697","volume":"27","author":"L Giuliani","year":"2007","unstructured":"Giuliani L, Favalli C, Syrjanen K, Ciotti M: Human papillomavirus infections in lung cancer. Detection of E6 and E7 transcripts and review of the literature. Anticancer Res. 2007, 27: 2697-704.","journal-title":"Anticancer Res"},{"key":"660_CR9","first-page":"2799","volume":"61","author":"YW Cheng","year":"2001","unstructured":"Cheng YW, Chiou HL, Sheu GT, Hsieh LL, Chen JT, Chen CY: The association of human papillomavirus 16\/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res. 2001, 61: 2799-2803.","journal-title":"Cancer Res"},{"key":"660_CR10","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1002\/cncr.11191","volume":"97","author":"HL Chiou","year":"2003","unstructured":"Chiou HL, Wu MF, Liaw YC, Cheng YW, Wong RH, Chen CY, Lee H: The presence of human papillomavirus type 16\/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer. 2003, 97: 1558-1563. 10.1002\/cncr.11191.","journal-title":"Cancer"},{"key":"660_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.lungcan.2008.10.003","volume":"65","author":"F Klein","year":"2009","unstructured":"Klein F, Amin Kotb WF, Petersen I: Incidence of human papilloma virus in lung cancer. Lung Cancer. 2009, 65: 13-18. 10.1016\/j.lungcan.2008.10.003.","journal-title":"Lung Cancer"},{"key":"660_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1146\/annurev.physiol.64.081501.155828","volume":"64","author":"S Zochbauer-Muller","year":"2002","unstructured":"Zochbauer-Muller S, Gazdar AF, Minna JD: Molecular pathogenesis of lung cancer. Annu Rev Physiol. 2002, 64: 681-708. 10.1146\/annurev.physiol.64.081501.155828.","journal-title":"Annu Rev Physiol"},{"key":"660_CR13","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/jcp.55.12.885","volume":"55","author":"KJ Syrianen","year":"2002","unstructured":"Syrianen KJ: HPV infections and lung cancer. J Clin Pathol. 2002, 55: 885-891. 10.1136\/jcp.55.12.885.","journal-title":"J Clin Pathol"},{"key":"660_CR14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H zur Hausen","year":"2002","unstructured":"zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002, 2: 342-350. 10.1038\/nrc798.","journal-title":"Nat Rev Cancer"},{"key":"660_CR15","doi-asserted-by":"publisher","first-page":"8148","DOI":"10.1038\/sj.onc.1205007","volume":"20","author":"L Carraresi","year":"2001","unstructured":"Carraresi L, Tripodi SA, Mulder LC, Bertini S, Nuti S, Schuerfeld K: Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6\/E7 oncogenes. Oncogene. 2001, 20: 8148-8153. 10.1038\/sj.onc.1205007.","journal-title":"Oncogene"},{"key":"660_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.canlet.2005.01.027","volume":"231","author":"L Carraresi","year":"2006","unstructured":"Carraresi L, Martinelli R, Vannoni A, Riccio M, Dembic M, Tripodi S: Establishment and characterization of murine small cell lung carcinoma cell lines derived from HPV-16 E6\/E7 transgenic mice. Cancer Lett. 2006, 231: 65-73. 10.1016\/j.canlet.2005.01.027.","journal-title":"Cancer Lett"},{"issue":"5 Suppl","key":"660_CR17","doi-asserted-by":"publisher","first-page":"106S","DOI":"10.1378\/chest.125.5_suppl.106S","volume":"125","author":"MM B\u00e9langer","year":"2004","unstructured":"B\u00e9langer MM, Roussel E, Couet J: Caveolin-1 is down-regulated in human lung carcinoma and acts as a candidate tumor suppressor gene. Chest. 2004, 125 (5 Suppl): 106S-10.1378\/chest.125.5_suppl.106S.","journal-title":"Chest"},{"issue":"8","key":"660_CR18","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-08-4210","volume":"69","author":"VC Daniel","year":"2009","unstructured":"Daniel VC, Marchionni L, Hierman JS, Rhodes JT, Devereux WL, Rudin CM: A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res. 2009, 69 (8): 3364-3373. 10.1158\/0008-5472.CAN-08-4210.","journal-title":"Cancer Res"},{"issue":"10","key":"660_CR19","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1158\/0008-5472.CAN-09-4228","volume":"70","author":"BE Schaffer","year":"2010","unstructured":"Schaffer BE, Park KS, Yiu G, Conklin JF, Lin C, Burkhart DL: Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma. Cancer Res. 2010, 70 (10): 3877-3883. 10.1158\/0008-5472.CAN-09-4228.","journal-title":"Cancer Res"},{"key":"660_CR20","first-page":"6","volume":"7","author":"A Rohrbeck","year":"2008","unstructured":"Rohrbeck A, Neukirchen J, Rosskopf M, Pardillos GG, Geddert H, Schwalen A: Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers. J Transl Med. 2008, 7: 6-69.","journal-title":"J Transl Med"},{"key":"660_CR21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ijc.1174","volume":"92","author":"R Klaes","year":"2001","unstructured":"Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U: Overexpression of p16 (INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001, 92: 276-284. 10.1002\/ijc.1174.","journal-title":"Int J Cancer"},{"key":"660_CR22","first-page":"795","volume":"6","author":"EE Jones","year":"2006","unstructured":"Jones EE, Wells SI: Cervical cancer and human papillomaviruses:inactivation of retinoblastoma and other tumor suppressor pathways. Curr Mol Med. 2006, 6: 795-808.","journal-title":"Curr Mol Med"},{"key":"660_CR23","doi-asserted-by":"publisher","first-page":"7874","DOI":"10.1038\/sj.onc.1204869","volume":"20","author":"F Mantovani","year":"2001","unstructured":"Mantovani F, Banks L: The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene. 2001, 20: 7874-7887. 10.1038\/sj.onc.1204869.","journal-title":"Oncogene"},{"key":"660_CR24","doi-asserted-by":"publisher","first-page":"7888","DOI":"10.1038\/sj.onc.1204860","volume":"20","author":"K Munger","year":"2001","unstructured":"Munger K, Basile JR, Duensing S: Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene. 2001, 20: 7888-7898. 10.1038\/sj.onc.1204860.","journal-title":"Oncogene"},{"key":"660_CR25","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1101\/gad.11.16.2101","volume":"11","author":"DL Jones","year":"1997","unstructured":"Jones DL, Alani RM, Munger K: The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p 21Cip1-mediated inhibition of cdk2. Genes Dev. 1997, 11: 2101-2111. 10.1101\/gad.11.16.2101.","journal-title":"Genes Dev"},{"key":"660_CR26","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.jcv.2004.11.019","volume":"32","author":"RD Steenbergen","year":"2005","unstructured":"Steenbergen RD, de Wilde J, Wilting SM, Brink AA, Snijders PJ, Meijer CJ: HPV-mediated transformation of the anogenital tract. J Clin Virol. 2005, 32: S25-33. 10.1016\/j.jcv.2004.11.019.","journal-title":"J Clin Virol"},{"key":"660_CR27","doi-asserted-by":"publisher","first-page":"5428","DOI":"10.1128\/JCM.43.11.5428-5434.2005","volume":"43","author":"S Bodaghi","year":"2005","unstructured":"Bodaghi S, Wood LV, Roby G, Ryder C, Steinberg SM, Zheng ZM: Could human papillomaviruses be spread through blood?. J Clin Microbiol. 2005, 43: 5428-5434. 10.1128\/JCM.43.11.5428-5434.2005.","journal-title":"J Clin Microbiol"},{"key":"660_CR28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.arcmed.2007.08.003","volume":"39","author":"G Anaya-Saavedra","year":"2008","unstructured":"Anaya-Saavedra G, Ram\u00edrez-Amador V, Irigoyen-Camacho ME, M\u00e9ndez- Mart\u00ednez R, Garc\u00eda-Carranc\u00e1 A: High association of human papillomavirus infection with oral cancer: a case-control study. Arch Med Res. 2008, 39: 189-197. 10.1016\/j.arcmed.2007.08.003.","journal-title":"Arch Med Res"},{"key":"660_CR29","first-page":"10","volume":"16","author":"X Wang","year":"2010","unstructured":"Wang X, Tian X, Liu F, Zhao Y, Sun M, Chen D: Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study. BMC Cancer. 2010, 16: 10-19.","journal-title":"BMC Cancer"},{"key":"660_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2407-10-117","volume":"26;10","author":"V Deschoolmeester","year":"2010","unstructured":"Deschoolmeester V, Van Marck V, Baay M, Weyn C, Vermeulen P, Van Marck E: Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer. BMC Cancer. 2010, 26;10: 117-10.1186\/1471-2407-10-117.","journal-title":"BMC Cancer"},{"key":"660_CR31","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","volume":"11","author":"S Marur","year":"2010","unstructured":"Marur S, D'Souza G, Westra WH, Forastiere AA: HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010, 11: 781-789. 10.1016\/S1470-2045(10)70017-6.","journal-title":"Lancet Oncol"},{"key":"660_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/MAJ.0b013e3181a393ba","volume":"338","author":"A Rezazadeh","year":"2009","unstructured":"Rezazadeh A, Laber DA, Ghim SJ, Jenson AB, Kloecker G: The role of human papilloma virus in lung cancer: a review of the evidence. Am J Med Sci. 2009, 338: 64-67. 10.1097\/MAJ.0b013e3181a393ba.","journal-title":"Am J Med Sci"},{"key":"660_CR33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1158\/0008-5472.CAN-09-3090","volume":"70","author":"Y Fan","year":"2010","unstructured":"Fan Y, Boivin GP, Knudsen ES, Nebert DW, Xia Y, Puga A: The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis. Cancer Res. 2010, 70: 212-220. 10.1158\/0008-5472.CAN-09-3090.","journal-title":"Cancer Res"},{"key":"660_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0009-2797(02)00069-8","volume":"141","author":"A Puga","year":"2002","unstructured":"Puga A, Xia Y, Elferink C: Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem Biol Interact. 2002, 141: 117-130. 10.1016\/S0009-2797(02)00069-8.","journal-title":"Chem Biol Interact"},{"key":"660_CR35","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.1128\/MCB.00323-07","volume":"27","author":"X Chang","year":"2007","unstructured":"Chang X, Fan Y, Karyala S, Schwemberger S, Tomlinson CR, Sartor MA: Ligand-independent regulation of transforming growth factor \u03b21 expression and cell cycle progression by the aryl hydrocarbon receptor. Mol Cell Biol. 2007, 27: 6127-6139. 10.1128\/MCB.00323-07.","journal-title":"Mol Cell Biol"},{"key":"660_CR36","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0026-895X(24)26518-4","volume":"57","author":"G Elizondo","year":"2000","unstructured":"Elizondo G, Fernandez-Salguero P, Sheikh MS, Kim GY, Fornace AJ, Lee KS: Altered cell cycle control at the G(2)\/M phases in aryl hydrocarbon receptor-null embryo fibroblast. Mol Pharmacol. 2000, 57: 1056-1063.","journal-title":"Mol Pharmacol"},{"key":"660_CR37","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1091\/mbc.E08-04-0359","volume":"19","author":"JL Marlowe","year":"2008","unstructured":"Marlowe JL, Fan Y, Chang X, Peng L, Knudsen ES, Xia Y: The aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis. Mol Biol Cell. 2008, 19: 3263-3271. 10.1091\/mbc.E08-04-0359.","journal-title":"Mol Biol Cell"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-9-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T12:50:20Z","timestamp":1740833420000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-9-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,4]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["660"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-9-2","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,4]]},"assertion":[{"value":"22 September 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"2"}}